Drug Type T-lymphocyte cell therapy |
Synonyms Deep Il-12 Primed T cell |
Target |
Mechanism IL-12R stimulants(Interleukin-12 receptor stimulants), IL-15Rα agonists(Interleukin-15 receptor subunit alpha agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Torque Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | US | Torque Therapeutics, Inc.Startup | - |
Solid tumor | Preclinical | US | - |